Discover Neuroscience
Systematic review of the neuroprotective potential of GLP1 receptor agonists and SGLT2 inhibitors in Alzheimer’s disease and cognitive impairment

Systematic review of randomized trialsSGLT2 inhibitors
Diabetes-associated cognitive decline
10 papers2 new in 30 days
